Tirzepatide 10 mg Nakon Medical

£180.00

Tirzepatide 10 mg Nakon Medical is a dual GIP/GLP-1 receptor agonist peptide originally developed for metabolic research applications. This synthetic peptide compound demonstrates potent effects on glucose homeostasis and energy regulation in preclinical models, making it valuable for laboratory studies examining metabolic pathways and hormone receptor interactions.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Tirzepatide 10 mg Nakon Medical
Tirzepatide 10 mg Nakon Medical
£180.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Peptide Research Overview

Tirzepatide 10 mg Nakon Medical is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for advanced metabolic research. This synthetic peptide represents a significant advancement in hormone receptor research, combining the activities of two incretin pathways in a single molecule. As a leading UK supplier, Stroid UK Shop provides this research-grade compound for in-vitro laboratory investigations examining metabolic signalling mechanisms and receptor pharmacology. Researchers investigating dual hormone receptor interactions will find this peptide particularly valuable for examining synergistic effects between GIP and GLP-1 pathways in controlled laboratory environments.

Laboratory Research Applications

This dual-acting peptide offers unique research opportunities for scientists studying metabolic regulation at the cellular level. Tirzepatide demonstrates superior potency compared to single-pathway agonists in preclinical models, making it an essential tool for examining enhanced metabolic responses. Research applications include investigating glucose homeostasis mechanisms, studying incretin hormone pathways, and examining the molecular basis of metabolic syndrome in laboratory models. The compound’s dual-receptor activity provides researchers with a sophisticated tool for studying complex hormone interactions that occur naturally in metabolic regulation. Scientists can examine how simultaneous GIP and GLP-1 receptor activation affects cellular signalling cascades, glucose uptake mechanisms, and energy expenditure pathways. This peptide is particularly valuable for laboratories investigating advanced metabolic modulators and their mechanisms of action. For comprehensive peptide research portfolios, our peptides collection offers complementary research compounds, while our SARMs category provides additional research tools for metabolic studies.

Technical Specifications

Tirzepatide 10 mg Nakon Medical Research Specifications
Parameter Specification
Peptide Name Tirzepatide
Supplier Nakon Medical
Concentration 10 mg per vial
Molecular Weight 4813.5 g/mol (approximate)
CAS Number 2023788-19-2
Purity ≥98% (HPLC verified)
Storage -20°C (lyophilised), 2-8°C (reconstituted)
Solubility Water, bacteriostatic water

Research Use Compliance

This Tirzepatide 10 mg Nakon Medical is supplied exclusively for in-vitro research purposes and is not intended for human consumption, clinical use, or any application outside of controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and local regulations governing peptide research compounds. This product is designed for qualified research professionals conducting studies in metabolic biochemistry, hormone receptor pharmacology, and related scientific disciplines. All research applications should follow established laboratory protocols for peptide handling and storage.

Related